Walgreens offers comprehensive expertise, services, and products to support people living with or at risk of diabetes. Operating nearly 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving nearly 10 million customers each day. Walgreens is committed to helping the diabetes community start and maintain an optimal regimen and routine to live a healthy life as a trusted member of their healthcare team, offering enhanced services focused on expanding access to affordable, local care. The company invests in special training to equip pharmacists with expert knowledge about medications, continuous glucose monitors, nutrition, how to keep A1C and blood glucose levels on target, and more. To best meet the needs of all customers and patients, Walgreens offers a true omnichannel experience, with fully integrated physical and digital platforms supported by the latest technology to deliver high-quality products and services in communities nationwide.
Diamond Level Sponsor
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Platinum Level Sponsor
Dexcom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.
Gold Level Sponsors
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s latest innovation, the Omnipod® 5 Automated Insulin Delivery System, is a tubeless automated insulin delivery system, integrated with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and is fully controlled by a compatible personal smartphone. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit insulet.com and omnipod.com.
Lilly unites caring with discovery to create medicines that make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer’s disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter, and LinkedIn.
Medtronic Diabetes is on a mission to alleviate the burden of diabetes by empowering individuals to live life on their terms, with the most advanced technology and always-on support when and how it is needed. Medtronic has pioneered first-of-its-kind innovations for over 40 years and is committed to designing the future of diabetes management through next-generation sensors (CGM), intelligent dosing systems, and the power of data science and AI while always putting the customer experience at the forefront. Today we offer the MiniMed™ 780G insulin pump system, the InPen™ smart insulin pen and the i-Port Advance™ injection port, and we continue to innovate further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. To learn more, visit www.medtronicdiabetes.com and follow us on Facebook, Instagram, TikTok, YouTube and LinkedIn.
Tandem Diabetes Care creates new possibilities for people living with diabetes, their loved ones, and their healthcare providers through a positively different experience. We manufacture and sell the t:slim X2 insulin pump with Control-IQ technology, but we’re so much more than that. Our company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Since many of our own team members live with type 1 diabetes, or have a loved one impacted by diabetes, the work is personal, and we are committed to the cause. Learn more at tandemdiabetes.com.
Silver Level Sponsor
Abbott, the worldwide leader in continuous glucose monitoring (CGM), is committed to improving the lives of people with diabetes. The company manufactures, distributes, and markets innovative glucose monitoring systems and other valuable services to help patients and healthcare professionals better manage diabetes care needs. Abbott is pleased to be a sponsor of Friends for Life Orlando Conference. Connect with us at https://freestyle.abbott/cwd, on Facebook at @FreeStyleUS on Instagram at @FreeStyleDiabetes, and on Twitter @FreeStyleDiabet.
Bronze Level Sponsors
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. In addition to our research funding and leadership, JDRF’s outreach efforts provide practical support and resources for people with T1D and their families every step of the way as they live with T1D. JDRF is proud to partner with Children with Diabetes by sponsoring national conferences and supporting sessions at Friends for Life. For more information, visit the JDRF website at www.jdrf.org, or call 800-533-CURE.
In 1923, the founders of Novo Nordisk began a journey to change diabetes. Today, we are thousands of employees across the world with the passion, the skills and the commitment to continue this journey to prevent, treat and ultimately cure diabetes. Novo Nordisk is proud to be a Bronze Level Sponsor of the Friends for Life conference, supporting the Family Fun Night. Please come see us at the exhibition to find out more about our company and our products. To learn more about Novo Nordisk and our support to the type 1 diabetes community, visit us at www.novonordisk-us.com.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including APOL1-mediated kidney disease, acute and neuropathic pain, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Xeris Pharmaceuticals, Inc., the maker of Gvoke HypoPen® (glucagon injection), is dedicated to unlocking the potential of glucagon. We believe that our technology can have a profound impact on the lives of patients and their families. That’s why we are proud to be the first to develop liquid glucagon, but that’s just the beginning. We’re also studying how our formulation technology can impact patients with other conditions. We have a persistent drive to pursue solutions that have the potential to change lives. Get to know us and see how our technology is unlocking the potential of today’s medicines at www.xerispharma.com.
Friends of CWD
AdaptHealth is changing lives by providing comprehensive best-in-class services while investing in the tools, technology, and people to enable our patients to live the highest quality of life. As one of the nation’s DME leaders in the Diabetes industry, AdaptHealth provides a comprehensive set of continuous glucose monitors (CGM), insulin pumps, and related supplies from the industry’s leading manufacturers. Simplify your Diabetes management with AdaptHealth and learn more about our extensive product support, information, and resources by visiting our website at Diabetes – AdaptHealth.
Beta Bionics is a public benefit corporation and certified B corp. committed to commercializing the iLet® bionic pancreas. We’re a people-focused company, here to serve the wider diabetes community. We want to make a difference and aim to improve the lives of people living with diabetes and hope to reduce the data and decision-making overload that PWD and their caregivers often deal with. To learn more about Beta Bionics, our team and our mission visit us at www.betabionics.com and @BetaBionics on social media.
The Certification Board for Diabetes Care and Education (CBDCE) is a not for profit certifying body that recognizes a number of different health professionals in the United States as having specialized knowledge about diabetes care and education. The organization name and certification designation underwent a change in 2020; you might be more familiar with the National Certification Board for Diabetes Educators or NCBDE and the Certified Diabetes Educator or CDE certification designation. The organization has been around since 1986, and the Certified Diabetes Care and Education Specialist or CDCES credential is seen as the gold standard in the diabetes world. Currently, over 19,900 health professionals hold the CDCES credential. CDCESs are committed and passionate about what the work they do in partnership with people with diabetes and their families and caregivers.
The Diabetes Patient Advocacy Coalition (DPAC) is an alliance of people with diabetes, caregivers, patient advocates, health professionals, diabetes organizations and companies working collaboratively to promote and support public policy initiatives to improve the health of all 37.3 million Americans with diabetes. We train people in the diabetes community on how to be advocates for themselves and their families. We work to ensure quality of and access to care, medications, and devices for patients living with diabetes; and to educate, inspire, and empower patient advocates as well as lawmakers toward meaningful action on diabetes.
Diamyd Medical develops precision medicine therapies for the prevention and treatment of Type 1 Diabetes and LADA (Latent Autoimmune Diabetes in Adults). Diamyd® is an antigen-specific immunotherapy for the preservation of endogenous insulin production that has Orphan Drug Designation in the U.S. and, in February 2024, was granted Fast Track designation by the U.S. FDA. DIAGNODE-3, a confirmatory Phase III trial is actively recruiting patients with recent-onset Type 1 Diabetes in eight European countries and in the US. Significant results have previously been shown in a large genetically predefined patient group – in a large-scale meta-analysis and in the Company’s European Phase IIb trial, where Diamyd® was administered directly into a superficial lymph node in children and young adults with recently diagnosed Type 1 Diabetes.
Founded in 2009 by T1D Carolyn Jäger, Sugar Medical set out to redefine diabetes accessories, transcending the mundane black glucometer cases and welcoming a collection of accessories that seamlessly blend style with functionality, allowing you to express your personal flair while making life with diabetes more manageable.
Today, Sugar Medical stands as one of the leading diabetic accessory companies nationwide with over 100 stylish designs. Each design is crafted with durability and practicality in mind, catering to the demands of daily life. Throughout the design process, Sugar Medical maintains a commitment to style, ensuring that its products not only serve a functional purpose but also exhibit meticulous attention to detail. Collaborations with industry leaders, such as Omnipod and Tandem Diabetes, enable Sugar Medical to produce accessories that seamlessly integrate with cutting-edge technologies, thereby enhancing the overall experience for individuals managing diabetes. Offering organizational solutions, Sugar Medical’s products are not just necessities—they are coveted accessories that people genuinely desire to carry.
CustomTypeOne was founded by Jon Fawcett after his daughter was diagnosed with type 1 at the age of 12. He dove head first into the DIY community and wrote the Loop Follow app as well as customized Loop patches used by thousands of DIY Loopers. These were developed because of his own daughter’s needs and then offered to the community as a way to make living with type 1 easier. After years of being actively involved in the DIY community, CustomTypeOne was founded with the goal of bringing some of the DIY benefits to everyone.
As his daughter grew older and was sleeping through her alerts, he recognized the need for an alert system that would wake a sleepy teenager from the deepest sleep especially knowing that she would soon be an independent adult. With that SugarPixel was created as a secondary alert system with randomized audio and vibration alerts to minimize alert fatigue. Its ability to wake the deepest of sleepers makes living with diabetes easier and safer. Due to its alerts, unique customization, and the ability to easily track up to two users from anywhere in the world, Sugar Pixel has quickly gained popularity and is now one of the top alert systems recommended to type ones. For more information, check out Sugar Pixel at CustomTypeOne.com.
T1D Exchange is a nonprofit organization that drives improved outcomes in the treatment of type 1 diabetes (T1D). Through quality improvement and collaboration, we harness data and insights to advance T1D research, identify unmet needs in diabetes care, refine best practices and ultimately improve the quality of life for all people living with T1D. The T1D Exchange Registry is a research study open to adults and children with T1D living in the United States. The Registry aims to show how people with T1D are currently doing and how aspects of T1D care and management change over time. Participants complete a questionnaire once per year and can participate in other optional T1D research studies through their Registry Dashboard.
The Diabetes Link’s mission is to empower young adults to thrive. We are the only national non-profit focused on individuals ages 16-30 who are living with diabetes. Our programs include a national peer network on college campuses and online; a free Resource Hub covering the topics most important for young adults; leadership opportunities as college chapter leaders or participation in the The Link Nextgen Fellowship program for those looking to enter the diabetes sector; and resources for allies such as parents, healthcare providers, campus administrators and roommates to better support young adults with diabetes as they transition to adulthood, or to campus. Connect with us: @thediabeteslink or www.thediabeteslink.org.
At 10 years old Elizabeth Forrest was diagnosed with type 1 diabetes and soon after declared diabetes wasn’t going to control her. Inspired by her middle school dance class, she combined her love for dance with her new diagnosis and created Dancing for Diabetes® as a way to bring attention to the millions who are living with Type 1 Diabetes and to raise funds to find a cure. Dancing for Diabetes® became a springboard for additional impactful programs that now make up the Touched by Type 1 organization which include: Dancing for Diabetes®, Kids & Teens with Diabetes Dance program, Type 1 @ School, Touched by Type 1 Annual Conference, Outreach, and the D-Box. Until a cure is found, Touched by Type 1 will continue to elevate awareness of Type 1 Diabetes, raise funds to find a cure, and inspire those with diabetes to thrive.